CD276 and neoplasm: Although induction of anxA1 expression in lung tumor vasculature was not as prevalent and widespread as that seen in other tumor vascular targets, notably B7-H3 [8] and PSMA [65, 66], these data validate anxA1 as a potential tumor vascular drug target in a proportion of human lung tumors.